Stéphane Verdood
Chief Executive Officer chez Vesalius Biocapital Holdings SA
Provenance du réseau au premier degré de Stéphane Verdood
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Medical Specialties | 35 | |
Apitope Technology (Bristol) Ltd.
Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
Vesalius Biocapital Partners SARL
Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg.
10
| Private Company | Investment Managers | 10 |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Apitope International NV
Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium.
6
| Subsidiary | Biotechnology | 6 |
Trod Medical NV
Trod Medical NV Medical SpecialtiesHealth Technology Trod Medical NV develops and commercializes tools for use in the focal ablation of soft tissues. The company was founded by Andre Scattolin Faure on June 29, 2006 and is headquartered in Leuven, Belgium.
5
| Holding Company | Medical Specialties | 5 |
Mara Venture Partners
2
| Extinct | Investment Managers | 2 |
Vesalius Biocapital II SA SICAR
Vesalius Biocapital II SA SICAR Investment ManagersFinance Vesalius Biocapital II SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project.
2
| Venture Capital Fund | Investment Managers | 2 |
Vesalius Biocapital II Arkiv NV
Vesalius Biocapital II Arkiv NV Investment ManagersFinance Vesalius Biocapital II Arkiv NV focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. Vesalius Biocapital Arkiv is part of the ARKImedes project, which is organized and/or managed by Participatiemaatschapij Vlaanderen NV.
1
| Venture Capital Fund | Investment Managers | 1 |
Vesalius Biocapital II Partners SARL
1
| Subsidiary | 1 | |
Vesalius Biocapital I SA SICAR
Vesalius Biocapital I SA SICAR Investment ManagersFinance Vesalius Biocapital I SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project.
1
| Venture Capital Fund | Investment Managers | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stéphane Verdood via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
STANDARD BIOTOOLS INC. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
SANOFI | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
TIGENIX NV | Medical Specialties | Chairman Director/Board Member Director/Board Member Public Communications Contact Corporate Officer/Principal | |
MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member | |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Limburgse Reconversie Maatschappij NV
Limburgse Reconversie Maatschappij NV Investment ManagersFinance Limburgse Reconversie Maatschappij NV (LRM) is an independent private equity firm which was founded in 1994 by the Flemish government. Limburgse Reconversie Maatschappij NV is headquartered in Hasselt, Beglium. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
University of London | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
ABLYNX | Biotechnology | Director/Board Member Director/Board Member | |
Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Hormos Medical Oy
Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
University College London | College/University | Doctorate Degree Undergraduate Degree | |
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder Director/Board Member | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
Université Libre de Bruxelles | College/University | Corporate Officer/Principal Graduate Degree | |
ESCP Europe Campus Paris | College/University | Graduate Degree Graduate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Graduate Degree | |
Ecole Supérieure de Commerce de Toulouse | College/University | Undergraduate Degree Masters Business Admin | |
Hasselt University | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Université Catholique de Louvain | College/University | Chairman Graduate Degree | |
Trinean NV
Trinean NV Electronic Equipment/InstrumentsElectronic Technology Trinean NV develops and produces nanoliter spectrophotometers and consumables. Its products include DropSense96, Xpose, and spectral content profiling. The firm covers both microfluidic structures and multi-channel spectrometry for microliter sample handling. The company was founded by Ronny Baeckstaele and Kris Naessens in 2006 and is headquartered in Gentbrugge, Belgium. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
SEPS Pharma NV
SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Director of Investments | |
Life Sciences Development Campus NV
Life Sciences Development Campus NV Miscellaneous Commercial ServicesCommercial Services Life Sciences Development Campus NV provides research and development services in the field of biomedical life sciences. The company is headquartered in Abis, BelGium. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Humedics GmbH
Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Packaged Software | Director/Board Member Chief Executive Officer | |
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam. | Investment Managers | Private Equity Investor Private Equity Investor | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman | |
SynAffix BV
SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Confo Therapeutics NV
Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Director/Board Member | |
iOnctura SA
iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Luciole Medical AG
Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Packaged Software | Director/Board Member Chief Executive Officer | |
LimmaTech Biologics AG
LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Founder Founder | |
Universite Paris Cite | College/University | Doctorate Degree Graduate Degree | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistiques
Internationale
Belgique | 14 |
France | 9 |
Pays-Bas | 7 |
Suisse | 7 |
Danemark | 6 |
Sectorielle
Health Technology | 21 |
Consumer Services | 16 |
Finance | 7 |
Commercial Services | 5 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 383 |
Corporate Officer/Principal | 129 |
Chairman | 82 |
Chief Executive Officer | 69 |
Independent Dir/Board Member | 39 |
Relations les plus connectées
Insiders | |
---|---|
Alfred Bouckaert | 44 |
Claus Asbjørn Andersson | 41 |
Viktor Drvota | 41 |
Baron Jean Stéphenne | 36 |
Alain Parthoens | 29 |
Stephan Christgau | 29 |
Roel Bulthuis | 29 |
Michael Gustav Brock | 22 |
Søren Møller | 21 |
Edward van Wezel | 20 |
William John Jenkins | 20 |
Frank Bulens | 20 |
Anja Koenig | 19 |
Hakan Goker | 18 |
Philippe Dro | 18 |
- Bourse
- Insiders
- Stéphane Verdood
- Connexions Sociétés